The latest price target for Mindset Pharma Inc Ordinary Shares (OTC:MSSTF) was reported by HC Wainwright & Co. on March 23, 2023. The analyst firm set a price target for $5.00 expecting MSSTF to rise to within 12 months (a possible 829.25% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Mindset Pharma Inc Ordinary Shares (OTC:MSSTF) was provided by HC Wainwright & Co., and Mindset Pharma Inc Ordinary Shares reiterated their buy rating.

There is no last upgrade for Mindset Pharma Inc Ordinary Shares

There is no last downgrade for Mindset Pharma Inc Ordinary Shares.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mindset Pharma Inc Ordinary Shares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mindset Pharma Inc Ordinary Shares was filed on March 23, 2023 so you should expect the next rating to be made available sometime around March 23, 2024.

While ratings are subjective and will change, the latest Mindset Pharma Inc Ordinary Shares (MSSTF) rating was a reiterated with a price target of $0.00 to $5.00. The current price Mindset Pharma Inc Ordinary Shares (MSSTF) is trading at is $0.54, which is within the analyst’s predicted range.